Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonoscopy | 6 | 2021 | 241 | 1.460 |
Why?
|
| Colorectal Neoplasms | 4 | 2021 | 612 | 0.960 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 262 | 0.900 |
Why?
|
| Health Educators | 1 | 2017 | 7 | 0.540 |
Why?
|
| Video Recording | 1 | 2019 | 193 | 0.530 |
Why?
|
| Career Mobility | 1 | 2017 | 51 | 0.520 |
Why?
|
| Neurilemmoma | 1 | 2017 | 39 | 0.500 |
Why?
|
| Preoperative Care | 1 | 2019 | 357 | 0.490 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 37 | 0.490 |
Why?
|
| Career Choice | 1 | 2017 | 165 | 0.470 |
Why?
|
| Mass Screening | 4 | 2021 | 817 | 0.430 |
Why?
|
| Gastroenterology | 1 | 2017 | 224 | 0.430 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2015 | 65 | 0.420 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 67 | 0.380 |
Why?
|
| Patient Compliance | 1 | 2016 | 462 | 0.380 |
Why?
|
| Amyloidosis | 1 | 2013 | 70 | 0.370 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 550 | 0.350 |
Why?
|
| Diarrhea | 2 | 2013 | 299 | 0.350 |
Why?
|
| Intestine, Small | 1 | 2013 | 291 | 0.340 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 130 | 0.340 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 416 | 0.310 |
Why?
|
| Algorithms | 3 | 2015 | 1662 | 0.310 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 683 | 0.310 |
Why?
|
| Antidiarrheals | 1 | 2009 | 17 | 0.310 |
Why?
|
| Referral and Consultation | 1 | 2012 | 551 | 0.280 |
Why?
|
| Diabetes Complications | 1 | 2009 | 197 | 0.270 |
Why?
|
| Genetic Testing | 2 | 2015 | 1105 | 0.260 |
Why?
|
| Celiac Disease | 2 | 2019 | 73 | 0.210 |
Why?
|
| Axonal Transport | 1 | 2003 | 24 | 0.200 |
Why?
|
| Histoplasma | 1 | 2013 | 37 | 0.190 |
Why?
|
| Colonic Diseases | 1 | 2013 | 36 | 0.190 |
Why?
|
| Histoplasmosis | 1 | 2013 | 55 | 0.190 |
Why?
|
| Histocytochemistry | 2 | 2017 | 85 | 0.170 |
Why?
|
| Occult Blood | 1 | 2021 | 31 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 407 | 0.160 |
Why?
|
| Colon | 1 | 2013 | 362 | 0.160 |
Why?
|
| Wheat Hypersensitivity | 1 | 2019 | 3 | 0.150 |
Why?
|
| Middle Aged | 6 | 2021 | 28314 | 0.150 |
Why?
|
| Humans | 16 | 2021 | 130066 | 0.150 |
Why?
|
| Cathartics | 1 | 2019 | 30 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1455 | 0.140 |
Why?
|
| Diverticulitis | 1 | 2018 | 7 | 0.140 |
Why?
|
| Duodenal Diseases | 1 | 2018 | 28 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 1076 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 1207 | 0.130 |
Why?
|
| Dyspepsia | 1 | 2018 | 108 | 0.130 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 48 | 0.120 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 187 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2018 | 316 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 968 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2013 | 191 | 0.090 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 86 | 0.090 |
Why?
|
| Medical Audit | 1 | 2012 | 97 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2013 | 229 | 0.090 |
Why?
|
| Loperamide | 1 | 2009 | 8 | 0.080 |
Why?
|
| Octreotide | 1 | 2009 | 23 | 0.080 |
Why?
|
| Clonidine | 1 | 2009 | 30 | 0.080 |
Why?
|
| Male | 5 | 2019 | 64378 | 0.080 |
Why?
|
| Sweetening Agents | 1 | 2009 | 37 | 0.080 |
Why?
|
| Incidence | 2 | 2012 | 3321 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2012 | 709 | 0.070 |
Why?
|
| Colitis | 1 | 2009 | 164 | 0.070 |
Why?
|
| Metformin | 1 | 2009 | 173 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 774 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1166 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2573 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 4035 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 476 | 0.060 |
Why?
|
| Adult | 3 | 2019 | 31012 | 0.060 |
Why?
|
| Decapodiformes | 1 | 2003 | 5 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 78 | 0.050 |
Why?
|
| Female | 4 | 2019 | 70239 | 0.050 |
Why?
|
| Huntingtin Protein | 1 | 2003 | 61 | 0.050 |
Why?
|
| Aged | 2 | 2017 | 20820 | 0.050 |
Why?
|
| Guatemala | 1 | 2013 | 63 | 0.050 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 43 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2003 | 108 | 0.050 |
Why?
|
| Poisson Distribution | 1 | 2012 | 50 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2057 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 128 | 0.050 |
Why?
|
| United States | 2 | 2012 | 11893 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 2687 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6165 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 975 | 0.040 |
Why?
|
| SEER Program | 1 | 2012 | 213 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2012 | 759 | 0.040 |
Why?
|
| Texas | 1 | 2009 | 3655 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 704 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 4 | 0.040 |
Why?
|
| Glutens | 1 | 2019 | 11 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 232 | 0.040 |
Why?
|
| Duodenoscopy | 1 | 2018 | 16 | 0.030 |
Why?
|
| Survival Rate | 1 | 2012 | 2108 | 0.030 |
Why?
|
| Duodenum | 1 | 2018 | 111 | 0.030 |
Why?
|
| Risk Factors | 1 | 2009 | 10959 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1264 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12818 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3407 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6765 | 0.020 |
Why?
|
| Animals | 1 | 2003 | 33641 | 0.010 |
Why?
|